Evidence map›Paper›PMID 37074350›Full record

ArticleThe Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association2023

Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study.

Yih-Ing Hser, Larissa J Mooney, Laura-Mae Baldwin, Allison Ober, Lisa A Marsch, Seth Sherman, Abigail Matthews, Sarah Clingan, Zhe Fei, Yuhui Zhu and 17 more

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04418453 (Rural Expansion of Medication Treatment for Opioid Use Disorder), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04418453 completednot on this map

Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD): Phase 1 Feasibility Study (CTN-0102)

TypeobservationalSponsorUniversity of California, Los AngelesRan2020 to 2021Enrolled36,762ConditionsOpioid-use DisorderArmsIntegration of telemedicine for MOUD in primary care
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Medication treatment for opioid use disorder among rural primary care patients.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2024
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Yih-Ing HserDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.ORCID 0000-0002-5809-739X
Larissa J MooneyDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Laura-Mae BaldwinDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Allison OberRAND Corporation, Santa Monica, California, USA.
Lisa A MarschCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Seth ShermanData and Statistical Center, the Emmes Company, Rockville, Maryland, USA.
Abigail MatthewsData and Statistical Center, the Emmes Company, Rockville, Maryland, USA.
Sarah ClinganDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Zhe FeiDepartment of Biostatistics, University of California, Los Angeles, California, USA.
Yuhui ZhuDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Alex DoppRAND Corporation, Santa Monica, California, USA.
Megan E CurtisDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Katie P OsterhageDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Emily G HichbornCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Chunqing LinSemel Institute for Neuroscience and Human Behavior, Center for Community Health, University of California, Los Angeles, California, USA.
Megan BlackDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.ORCID 0000-0001-5099-9666
Stacy CalhounDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Caleb C HoltzerProvidence, Colville, Washington, USA.
Noah NesinPenobscot Community Health Care, Bangor, Maine, USA.
Denise BouchardPenobscot Community Health Care, Belfast, Maine, USA.
Maja LedgerwoodRural Social Service Solutions, LLC, New Meadows, Idaho, USA.
Margaret A GehringSt. Mary's Health, Cottonwood, Idaho, USA.
Yanping LiuCenter for Clinical Trials Network, National Institute on Drug Abuse, Bethesda, Maryland, USA.
Neul Ah HaClinical Coordinating Center, Emmes Company, Rockville, Maryland, USA.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medical College, New York, New York, USA.
Maria HananoDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Andrew J SaxonVeterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Project-002UG1DA040309 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2015 to 2026
$37.9M
Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
Greater Southern California Node of the Clinical Trials NetworkUG1DA049435 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YIH-ING HSER · 2019 to 2026
$16.7M
MYCOBACTERIUM AVIUM-INTRACELLULARE IN AIDSZ01CL000013 · CLC · CLINICAL CENTER · PI MASUR, H · 1985 to 1986
–
CLC NIH HHS 75N90019D00013NCATS NIH HHS UL1 TR002319NIDA NIH HHS 75N95021D00013NIDA NIH HHS P30 DA029926NIDA NIH HHS UG1 DA013714NIDA NIH HHS UG1 DA040309NIDA NIH HHS UG1 DA049435NIMH NIH HHS P30 MH058107ORFDO NIH HHS 75N99019D00013
6 · The paper itself

Abstract

purposeThe use of telemedicine (TM) has accelerated in recent years, yet research on the implementation and effectiveness of TM-delivered medication treatment for opioid use disorder (MOUD) has been limited. This study investigated the feasibility of implementing a care coordination model involving MOUD delivered via an external TM provider for the purpose of expanding access to MOUD for patients in rural settings.

methodsThe study tested a care coordination model in 6 rural primary care sites by establishing referral and coordination between the clinic and a TM company for MOUD. The intervention spanned approximately 6 months from July/August 2020 to January 2021, coinciding with the peak of the COVID-19 pandemic. Each clinic tracked patients with OUD in a registry during the intervention period. A pre-/post-intervention design (N = 6) was used to assess the clinic-level outcome as patient-days on MOUD based on patient electronic health records.

findingsAll clinics implemented critical components of the intervention, with an overall TM referral rate of 11.7% among patients in the registry. Five of the 6 sites showed an increase in patient-days on MOUD during the intervention period compared to the 6-month period before the intervention (mean increase per 1,000 patients: 132 days, P = .08, Cohen's d = 0.55). The largest increases occurred in clinics that lacked MOUD capacity or had a greater number of patients initiating MOUD during the intervention period.

conclusionsTo expand access to MOUD in rural settings, the care coordination model is most effective when implemented in clinics that have negligible or limited MOUD capacity.

Indexed as

COVID-19Opioid-Related DisordersTelemedicineFeasibility StudiesHumansPandemicsPrimary Health Carecare coordinationmedication for opioid use disorderopioid use disorderprimary carerural communitytelemedicine

Identifiers

PMID37074350
PMCPMC10718290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.